Literature DB >> 12006432

The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.

Koang H Choi1, Heung B Lee, Min Y Jeong, Yang K Rhee, Myung J Chung, Yong G Kwak, Yong C Lee.   

Abstract

BACKGROUND: The processes observed in interstitial lung disease are associated with the production, deposition, and proteolysis of the extracellular matrix (ECM), which may lead to irreversible pulmonary structural remodeling or to appropriate repair without fibrosis. Matrix metalloproteinases (MMPs) and a tissue inhibitor of metalloproteinases (TIMPs) are known to regulate remodeling of the ECM and thus to be important in the process of lung fibrosis. Pulmonary structures are extensively remodeled in usual interstitial pneumonia (UIP), whereas severe architectural remodeling is minimally present in cryptogenic organizing pneumonia (COP). However, not much is known about the roles of MMP-9 and/or TIMP-1 in COP.
METHODS: Levels of MMP-9, TIMP-1 and the molar ratio of MMP-9/TIMP-1 in BAL fluids were investigated in 11 patients with UIP, in 8 patients with COP, and in 10 control subjects. We checked the levels of MMP-9 and TIMP-1 by means of enzyme immunoassay, and the hydrolytic activity of MMP-9 in BAL fluids was measured by gelatin zymography. Further, we evaluated the expression of MMP-9 and TIMP-1 in lung tissue by immunohistochemistry.
RESULTS: The concentrations of MMP-9 and TIMP-1 were significantly increased in patients with UIP and were even higher in patients with COP compared with control subjects. The levels of MMP-9 and TIMP-1 were significantly higher in patients with COP than in patients with UIP. The molar ratio of MMP-9/TIMP-1 was significantly higher in patients with COP than in control subjects. In patients with COP, the concentration of MMP-9 significantly correlated with the number of neutrophils and lymphocytes. Zymographic analysis revealed that the activity of the 92-kd pro-MMP-9 was increased in patients with UIP and was even higher in patients with COP, compared with control subjects.
CONCLUSIONS: These data suggest that overproduction of MMP-9 and TIMP-1, and an imbalance between MMP-9 and TIMP-1, may have a role as diagnostic references in COP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12006432     DOI: 10.1378/chest.121.5.1478

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

2.  Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.

Authors:  Yuan-Hung Yeh; Junn-Liang Chang; Pei-Ching Hsiao; Shih-Ming Tsao; Chien Huang Lin; Shang-Jyh Kao; Ming-Chih Chou; Shun-Fa Yang; Ming-Hsien Chien
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

Review 3.  Matrix metalloproteinases in destructive pulmonary pathology.

Authors:  P T G Elkington; J S Friedland
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

4.  Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity.

Authors:  Peter Chen; John K McGuire; Robert C Hackman; Kyoung-Hee Kim; Roy A Black; Kurt Poindexter; Wei Yan; Phillip Liu; Ann J Chen; William C Parks; David K Madtes
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

5.  Potential involvement of gelatinases and their inhibitors in Mannheimia haemolytica pneumonia in cattle.

Authors:  Amanda E Starr; Tonima Dan; Kanwal Minhas; Patricia E Shewen; Brenda L Coomber
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels.

Authors:  Tetsu Kobayashi; HuiJung Kim; Xiangde Liu; Hisatoshi Sugiura; Tadashi Kohyama; Qiuhong Fang; Fu-Qiang Wen; Shinji Abe; Xingqi Wang; Jeffrey J Atkinson; James M Shipley; Robert M Senior; Stephen I Rennard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-04       Impact factor: 5.464

7.  Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury.

Authors:  Kamalakar C Nerusu; Roscoe L Warner; Narasimharao Bhagavathula; Shannon D McClintock; Kent J Johnson; James Varani
Journal:  Exp Mol Pathol       Date:  2007-05-04       Impact factor: 3.362

8.  Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia.

Authors:  Tomio Matsumoto; Keisuke Hayamizu; Seiji Marubayashi; Kiyoshi Shimizu; Aki Hamamoto; Tsuyoshi Yamaguchi; Junji Hashizume; Takashi Onabe; Toshimasa Asahara; Hideki Ohdan
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

9.  Association of circulating levels of MMP-8 with mortality from respiratory disease in patients with rheumatoid arthritis.

Authors:  Derek L Mattey; Nicola B Nixon; Peter T Dawes
Journal:  Arthritis Res Ther       Date:  2012-10-02       Impact factor: 5.156

10.  Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.

Authors:  Ji Young Kim; Hyun Cheol Choeng; Cheolmin Ahn; Sang-Ho Cho
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.